Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis

Annals of the Rheumatic Diseases

Volumn 65, Issue 12, 2006, Pages 1565-1571

  Dorph, C ^a   Englund, P ^a   Nennesmo, I ^a   Lundberg, I E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD3 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MACROPHAGE; MALE; MICROSCOPY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE DISEASE; MUSCLE WEAKNESS; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOPSY; DERMATOMYOSITIS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-1ALPHA; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; POLYMYOSITIS; RECEPTORS, CELL SURFACE; T-LYMPHOCYTE SUBSETS;

EID: 33751305449     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.051086     Document Type: Article

References (34)

1. Bunch TW, Worthington JW, Combs JJ, Ilstrup DM, Engel AG. Azathioprine with prednisone for polymyositis. A controlled, clinical trial. Ann Intern Med 1980;92:365-9.
2. Nyberg P, Wikman AL, Nennesmo I, Lundberg I. Increased expression of interleukin 1 alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheumatol 2000;27:940-8.
3. Olsen NJ, Park JH. Inflammatory myopathies: issues in diagnosis and management. Arthritis Care Res 1997;10:200-7.
4. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989;111:143-57.
5. Englund P, Nennesmo I, Klareskog L, Lundberg IE. Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Arthritis Rheum 2002;46:1044-55.
6. Lundberg I, Kratz AK, Alexanderson H, Patarroyo M. Decreased expression of interleukin-1 alpha, interleukin-1 beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Arthritis Rheum 2000;43:336-48.
7. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibilily complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 1989;20:224-31.
8. Appleyard ST, Dunn MJ, Dubowitz V, Rose ML. Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders. Lancet 1985;1:361-3.
9. Bartoccioni E, Gallucci S, Scuderi F, Ricci E, Servidei S, Broccolini A, et al. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin Exp Immunol 1994;95:166-72.
10. Inukai A, Kuru S, Liang Y, Takano A, Kobayashi Y, Sakai M, et al. Expression of HLA-DR and its enhancing molecules in muscle fibers in polymyositis. Muscle Nerve 2000;23:385-92.
11. Karpati G, Pouliot Y, Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988;23:64-72.
12. Nogaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E, et al. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA 2000;97:9209-14.
13. Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997;40:865-74.
14. Carry MR, Ringel SP, Starcevich JM. Distribution of capillaries in normal and diseased human skeletal muscle. Muscle Nerve 1986;9:445-54.
15. Casademont J, Grau JM, Estruch R, Pedro-Botet JC, Urbano-Marquez A. Relationship between capillary and muscle damage in dermatomyositis. Int J Dermatol 1990;29:117-20.
16. Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990;27:343-56.
17. Estruch R, Grau JM, Fernandez-Sola J, Casademont J, Monforte R, Urbano-Marquez A. Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. Hum Pathol 1992;23:888-95.
18. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
19. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
20. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-13.
21. Josefsson A, Romanus E, Carlsson J. A functional index in myositis. J Rheumatol 1996;23:1380-4.
22. Dorph C, Nennesmo I, Lundberg IE. Percutaneous conchotome muscle biopsy. A useful diagnostic and assessment tool. J Rheumatol 2001;28:1591-9.
23. Henriksson KG. "Semi-open" muscle biopsy technique. A simple outpatient procedure. Acta Neurol Scand 1979;59:317-23.
24. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999;145:33-43.
25. Engel AG, Franzini-Armstrong C. Myology: basic and clinical. London: McGraw-Hill, 1994.
26. van der Pas J, Hengstman GJ, ter Laak HJ, Borm GF, van Engelen BG. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry 2004;75:136-9.
27. De Bleecker JL, Engel AG. Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy. J Neuropathol Exp Neurol 1994;53:369-76.
28. Cid MC, Grau JM, Casademont J, Tobias E, Picazo A, Coll-Vinent B, et al. Leucocyte/endothelial cell adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies (UM). Clin Exp Immunol 1996;104:467-73.
29. Tidball JG, Wehlinq-Henricks M. Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis. Curr Opin Rheumatol 2005;17:707-13.
30. Park JH, Vital TL, Ryder NM, Hernanz-Schulman M, Partain CL, Price RR, et al. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arthritis Rheum 1994;37:736-46.
31. Taylor PC. VEGF and imaging of vessels in rheumatoid arthritis. Arthritis Res 2002;4(Suppl 3):S99-107.
32. Blake DR, Merry P, Unsworth J, Kidd BL, Outhwaite JM, Bollard R, et al. Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1989;1:289-93.
33. Shreeniwas R, Koga S, Karakurum M, Pinsky D, Kaiser E, Brett J, et al. Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest 1992;90:2333-9.
34. Niinikoski J, Paljarvi L, Laato M, Lang H, Panelius M. Muscle hypoxia in myositis. J Neurol Neurosurg Psychiatry 1986;49:1455.